With Eye Toward Uniformity, Kentucky Reviews Drug Rules: Blood-Horse 2/1/17

By: Frank Angst After an in-depth review of its racing medication rules relative to the Association of Racing Commissioners International’s recommendations, a Kentucky council is recommending penalty classification changes for a pair of medications. The Kentucky Equine Drug Research Council recommended Feb. 1 that the expectorant ambroxol (Ambril) be moved to a more severe penalty

AAEP Announces Initiative to Enhance Horse Health, Racing Integrity: AAEP.org 7/28/15

Press release AAEP Announces Initiative to Enhance Horse Health, Racing Integrity Prescription for Racing Reform to seek non-race day EIPH treatments, support 48-hour NSAID rule The American Association of Equine Practitioners today announced a multi-part initiative to protect the health and welfare of the racehorse and help ensure the long-term viability of the racing industry

KEDRC Makes Cobalt Policy Recommendation: The Blood-Horse 5/26/15

RMTC By Frank Angst The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt rules on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation. The KEDRC voted May 26 at the Kentucky Horse Park to recommend a Class B penalty when horses test above 50